Involvement of the fecal amino acid profile in a clinical and anthropometric study of Mexican patients with insulin resistance and type 2 diabetes mellitus

被引:0
|
作者
Mayra Paloma Macías-Acosta
Lorena Valerdi-Contreras
Ericka Denise Bustos-Angel
Rudy Antonio García-Reyes
Monserrat Alvarez-Zavala
Marisela González-Ávila
机构
[1] Center for Research and Assistance in Technology and Design of the State of Jalisco (CIATEJ),Department Medical and Pharmaceutical Biotechnology
[2] A.C.,Clinical Medicine Department
[3] Head of the Medical Division and Assigned to Internal Medicine Department of Antiguo Civil Hospital of Guadalajara “Fray Antonio Alcalde”,undefined
[4] Assigned to the Internal Medicine Department of Antiguo Civil Hospital of Guadalajara “Fray Antonio Alcalde”,undefined
[5] University Center of Health Sciences-University of Guadalajara,undefined
来源
Amino Acids | 2022年 / 54卷
关键词
Fecal amino acids; Fecal branched-chain amino acids; Intestinal microbiota; Type 2 diabetes mellitus; Insulin resistance;
D O I
暂无
中图分类号
学科分类号
摘要
The amino acids synthesized by the intestinal microbiota have been correlated with metabolic diseases, such as type 2 diabetes mellitus and insulin resistance; both are high incidence conditions in Mexico. However, the knowledge of the relationship of fecal amino acids with the development of both diseases in the Mexican population is scarce. The clinical study was descriptive; the study was carried out in the Antiguo Civil Hospital of Guadalajara. Samples were taken from a total of 48 participants with insulin resistance, diabetes, and a control group (n = 16 each). Anthropometric and biochemical measures were evaluated. HPLC carried out the quantification of fecal amino acids. A strong correlation between alanine and HOMA-IR (r = 0.5416) was found and between phenylalanine and HOMA-IR (r = 0.4258). Other interesting correlations were between alanine and glucose (r = 0.5854) and isoleucine and glucose (r = 0.5008). The diabetic group and the insulin-resistant group had increased fecal values of valine and isoleucine (branched-chain amino acids), which were positively correlated with the progression of both conditions. Likewise, alanine and phenylalanine can help predict the development of the disease in the Mexican population. Registry number: 037/19.
引用
收藏
页码:47 / 55
页数:8
相关论文
共 50 条
  • [41] Obesity is the alleyway to insulin resistance and Type 2 diabetes mellitus
    Sinha, Susmita
    Haque, Mainul
    ADVANCES IN HUMAN BIOLOGY, 2022, 12 (02) : 207 - 209
  • [42] The role of mitochondria in insulin resistance and type 2 diabetes mellitus
    Szendroedi, Julia
    Phielix, Esther
    Roden, Michael
    NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (02) : 92 - 103
  • [43] The role of interleukins in insulin resistance and type 2 diabetes mellitus
    Bruno Fève
    Jean-Philippe Bastard
    Nature Reviews Endocrinology, 2009, 5 : 305 - 311
  • [44] Molecular mechanisms of insulin resistance in type 2 diabetes mellitus
    Saini, Vandana
    WORLD JOURNAL OF DIABETES, 2010, 1 (03): : 68 - 75
  • [45] Role of the inflammasome in insulin resistance and type 2 diabetes mellitus
    Lu, Shen
    Li, Yanrong
    Qian, Zhaojun
    Zhao, Tiesuo
    Feng, Zhiwei
    Weng, Xiaogang
    Yu, Lili
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [46] Type 2 Diabetes Mellitus in Childhood: Obesity and Insulin Resistance
    Schwartz, Malcolm S.
    Chadha, Anila
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2008, 108 (09): : 518 - 524
  • [47] Current treatment of insulin resistance in type 2 diabetes mellitus
    Tan, MH
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, : 54 - 62
  • [48] The role of interleukins in insulin resistance and type 2 diabetes mellitus
    Feve, Bruno
    Bastard, Jean-Philippe
    NATURE REVIEWS ENDOCRINOLOGY, 2009, 5 (06) : 305 - 311
  • [49] Type 2 Diabetes Mellitus, Insulin Resistance, and Vitamin D
    Alan Sacerdote
    Paulomi Dave
    Vladimir Lokshin
    Gül Bahtiyar
    Current Diabetes Reports, 2019, 19
  • [50] Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus
    Björntorp, P
    Holm, G
    Rosmond, R
    DIABETIC MEDICINE, 1999, 16 (05) : 373 - 383